Medical Patent News

RSS

US District Court rules in favor of Watson in FENTORA patent litigation

On March 11, 2011, the United States District Court for the District of Delaware issued a decision as to a portion of the patent litigation brought by Cephalon Inc., and its wholly-owned subsidiary CIMA Labs, Inc., against Watson Pharmaceuticals, Inc., and its wholly-owned subsidiary Watson Laboratories, Inc., pertaining to Cephalon's FENTORA® fentanyl buccal tablet product.

14 Mar 2011

Israel grants patent to Kamada's Transferrin for use in Pharmaceutical Compositions

Kamada, a biopharmaceutical company developing, manufacturing and marketing specialty life-saving therapeutics, announced today it has received an Israeli Patent for its Ultrapure Transferrin to be used in Pharmaceutical Compositions.

10 Mar 2011

Salient settles patent infringement lawsuit against Bovie Medical

Salient Surgical Technologies, Inc., a privately held medical technology company that develops and markets advanced energy devices for use in surgical procedures, announced today a settlement in the Company's patent infringement lawsuit against Bovie Medical.

10 Mar 2011

PILMA praises Senate for 2011 Patent Protection Act

The Pharmaceutical Industry Labor Management Association applauds tonight's decisive action by the Senate in passing the 2011 Patent Protection Act. The strong 95 to 5 vote is a solid indication that the bill meets the concerns from both sides of the aisle.

9 Mar 2011

USPTO grants new patent to Intellect's Alzheimer's vaccine

Intellect Neurosciences, Inc., a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced today that it has received a new patent from the United States Patent and Trademark Office in relation to the Company's RECALL-VAXTM technology platform.

9 Mar 2011

USPTO grants patent to Symphogen's Sym004 to treat solid tumors

Symphogen, a private biopharmaceutical company developing superior antibody therapeutics, said the company had been granted a US patent for Sym004 as well as other antibody compositions containing at least two distinct anti-EGFR antibodies having certain binding characteristics.

7 Mar 2011

Oxford Instruments patents to be auctioned off at ICAP Ocean Tomo's Spring 2011 Live IP Auction

The Oxford Instruments patents will be auctioned off at ICAP Ocean Tomo's Spring 2011 Live IP Auction on March 31, 2011 in New York City. Oxford Instruments has determined that these patents are not strategic for its ongoing business. The lots include: a concept for the use of magnetic particles for targeted cancer treatment, advanced sterilization techniques, an advanced imaging system, and an advanced microbolometer.

5 Mar 2011

Bovie settles patent infringement ligation with Salient Surgical and Medtronic

Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced a settlement to the June 10, 2010, action brought by Salient Surgical Technologies, Inc. and Medtronic, Inc. against the Company.

5 Mar 2011

Stockholm court rules in favour of Occlutech against AGA-St Jude Medical

Occlutech GmbH, a leading European developer of minimally invasive implants for the treatment of structural heart disease, today announced that it has received a favourable court ruling from Stockholm, Sweden in the on-going patent litigation with AGA Medical -St Jude Medical.

5 Mar 2011

Hemispherx, Chronix jointly file US patent application for CFS blood test

Chronix Biomedical announced today that it filed a provisional United States patent application jointly with Hemispherx Biopharma, Inc. on a blood test for Chronic Fatigue Syndrome.

4 Mar 2011

Trial date set for Teva's generic COPAXONE patent infringement litigation against Momenta

Teva Pharmaceutical Industries Ltd. today announced that the United States District Court for the Southern District of New York has set a trial date of September 7, 2011 in the Company's ongoing patent infringement litigation against Momenta Pharmaceuticals, Inc./Sandoz Inc. and Mylan Pharmaceuticals, Inc./Mylan Inc./Natco Pharma Ltd. regarding their purported generic versions of COPAXONE® (glatiramer acetate injection).

2 Mar 2011

Court case question: Who holds the patent — drug company or research institution

The invention of an AIDS test is a big deal, and it takes a lot of time, smarts and money to develop a good one. So there's a lot at stake in the legal tussle between Stanford University and the pharmaceutical giant Roche, with oral arguments opening Monday before the U.S. Supreme Court.

2 Mar 2011

GenMark announces dismissal of microfluidic technology patent lawsuit against Caliper Life Sciences

GenMark Diagnostics Inc. announced today that it has dismissed a lawsuit in the Northern District of California pending since November 2010 that requested declaratory relief that it does not infringe three U.S. patents on microfluidic technology allegedly owned by Caliper Life Sciences, Inc.

2 Mar 2011

EPO to grant patent for Apricus MycoVa product to treat nail fungus

Apricus Biosciences, Inc. announced today that the European Patent Office will grant a patent for the company's MycoVa product for treating onychomycosis.

2 Mar 2011

EPO cancels PDL's '216B European Patent

PDL BioPharma, Inc. announced today that the Technical Board of Appeal of the European Patent Office has cancelled its hearing in which three appellants sought to have a 2007 decision upholding PDL's European Patent No. 0 451 216B overturned and the patent revoked.

1 Mar 2011

Cummings School granted U.S. Patent for antibody-based treatment against Hemolytic Uremic Syndrome

Researchers at the Cummings School of Veterinary Medicine have received U.S. patent approval for an antibody-based treatment for Hemolytic Uremic Syndrome (HUS), a potentially fatal outcome of E. coli poisoning and the leading cause of kidney failure in children.

1 Mar 2011

EPO grants three core patents to caprotec's CCMS technology

caprotec bioanalytics GmbH announced today that the European Patent Office has granted the last of three core patents protecting its proprietary and revolutionary Capture Compound Mass Spectrometry technology.

28 Feb 2011

Rexahn's novel anti-cancer quinoxalinyl-piperazine compounds granted European patent

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office has granted European patent No. 1819698 to Rexahn for its novel anti-cancer quinoxalinyl-piperazine compounds.

28 Feb 2011

U.S. District Court rules in favor of Hologic in breast brachytherapy patent infringement lawsuit

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that the United States Court of Appeals for the Federal Circuit has ruled in favor of Hologic, by reversing the previous decisions reached by the United States District Court for the Northern District of California, in favor of SenoRx, Inc.

From Hologic, Inc. 28 Feb 2011

Aerocrine announces positive outcome of its patent proceedings against Medisoft

Aerocrine AB today announced the positive outcome of its patent proceedings against Medisoft P.A.E. at the Court of Appeal of Dusseldorf and the Federal Patent Court of Munich.

25 Feb 2011

Medical Patent News

US District Court rules in favor of Watson in FENTORA patent litigation

Israel grants patent to Kamada's Transferrin for use in Pharmaceutical Compositions

Salient settles patent infringement lawsuit against Bovie Medical

PILMA praises Senate for 2011 Patent Protection Act

USPTO grants new patent to Intellect's Alzheimer's vaccine

USPTO grants patent to Symphogen's Sym004 to treat solid tumors

Oxford Instruments patents to be auctioned off at ICAP Ocean Tomo's Spring 2011 Live IP Auction

Bovie settles patent infringement ligation with Salient Surgical and Medtronic

Stockholm court rules in favour of Occlutech against AGA-St Jude Medical

Hemispherx, Chronix jointly file US patent application for CFS blood test

Trial date set for Teva's generic COPAXONE patent infringement litigation against Momenta

Court case question: Who holds the patent — drug company or research institution

GenMark announces dismissal of microfluidic technology patent lawsuit against Caliper Life Sciences

EPO to grant patent for Apricus MycoVa product to treat nail fungus

EPO cancels PDL's '216B European Patent

Cummings School granted U.S. Patent for antibody-based treatment against Hemolytic Uremic Syndrome

EPO grants three core patents to caprotec's CCMS technology

Rexahn's novel anti-cancer quinoxalinyl-piperazine compounds granted European patent

U.S. District Court rules in favor of Hologic in breast brachytherapy patent infringement lawsuit

Aerocrine announces positive outcome of its patent proceedings against Medisoft

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News